Connecting Patient-level Clinical Trial Data to Real World Data | Medidata Link White Paper

Downloadable White Paper

Connecting Patient-level Clinical Trial Data to Real World Data: Unlocking New Insights with Medidata Link

Accessing compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. However, gaps between clinical trial data (CTD) and real world data (RWD) make it difficult to fully understand long-term outcomes and therapeutic efficacy.

These evidence gaps have a high cost. 86% of clinical trials are delayed by one to six months during pre-trial complex screening and baselining— costing time, money, and hindering clinical trial data collection. On average, clinical trials have a 28% patient attrition rate and a two to three year wait to accumulate RWD.

Introducing Medidata Link: the only centralized technology solution that works across multiple research sites to connect patient-level clinical trial data and real world data, powered by and fully integrated with the Medidata Clinical Cloud unified platform. Download this report to learn more about:

  • The Process of Linking CTD and RWD via Tokenization
  • Key Features of a Scalable Data Linkage Solution
  • Benefits for Patients, Sites, and Sponsors
  • Data Linkage Use Cases
Connecting Patient-level Clinical Trial Data to Real World Data: Unlocking New Insights with Medidata Link